“CBT works” is one of the most repeated claims in mental health, and it is approximately true and not very informative. A series of meta-analyses published in JAMA psychiatry set out to make it precise by asking the same question, the same way, about eleven different conditions. [pubmed-trauma-jul13-2026-source]
What the researchers did
Separate meta-analyses of CBT already existed for most disorders, but each used its own inclusion criteria, its own approach to assessing study quality, and its own statistics. That made cross-disorder comparison impossible: a bigger number in the OCD review than the depression review might reflect the treatment or might reflect the methodology.
This team applied one uniform method to all of them: identical search procedures, identical risk-of-bias assessment using the Cochrane tool, and identical meta-analytic technique.
The result covers 375 trials, 423 comparisons and 32,968 patients, across four anxiety disorders, two eating disorders, major depression, OCD, PTSD, and psychotic and bipolar disorders. Average patient age was 43, and about two thirds were women.
Every comparison was CBT against an inactive control, meaning a waiting list or similar.
What they found
The effects sort into three tiers.
Bands as reported by Cuijpers and colleagues (2025), JAMA psychiatry. Bars show the band each disorder fell into rather than its exact point estimate, and all comparisons were against inactive controls.
Largest, above 1.0: PTSD and specific phobia.
Moderate, between 0.5 and 1.0: panic disorder, social anxiety, generalised anxiety, depression, OCD, bulimia nervosa and binge eating disorder.
Smallest, below 0.5: bipolar and psychotic disorders.
Reading the ranking without over-reading it
Three things shape those numbers besides how well CBT works.
What the control group does. These are comparisons against no treatment. PTSD and specific phobias tend not to improve much on their own over a trial’s duration, so the untreated group stays put and the gap at the end is wide. Depression, by contrast, often improves somewhat without treatment, which narrows the measured difference even if the therapy is working equally well.
What CBT is being added to. For bipolar and psychotic disorders, CBT is delivered alongside medication, not instead of it. The effect being measured is what talking therapy adds on top of a treatment that is already doing most of the work. That is a harder bar, and a small number there means something different from a small number where CBT is the whole treatment.
Inactive controls inflate everything. Every figure here is CBT versus nothing. Against another active treatment, differences shrink considerably. These are real numbers answering a real question; they are not estimates of how much better CBT is than the alternatives.
Why it is a useful paper anyway
Because it replaces a slogan with a shape.
“CBT works” flattens a several-fold difference in expected benefit into a single claim. Knowing that the evidence is strongest for PTSD and phobias, solid for the common anxiety and mood disorders, and more modest as an add-on for bipolar and psychosis is genuinely better information for anyone deciding what to ask for or what to expect.
It also demonstrates something about evidence generally: the comparison group and the method determine the number at least as much as the treatment does. Two reviews reporting different effects for the same therapy may simply have counted differently.
If you are considering CBT
The practical reading is that CBT has good evidence across a wide range of conditions, that the size of the benefit depends on which condition, and that “evidence-based” describes a range rather than a promise to any one person.
Our trauma and PTSD guide covers the trauma-focused therapies at the top of this list, and our anxiety guide covers the disorders in the middle band.
The source
These findings are drawn from “Cognitive Behavior Therapy for Mental Disorders in Adults: A Unified Series of Meta-Analyses” (Cuijpers P, Harrer M, Miguel C, et al., 2025), published in JAMA psychiatry. Read the full study on PubMed.